Sarcoma (Soft Tissue Sarcoma) Summary

Networked: 14738 relevant articles (680 outcomes, 1946 trials/studies) for this Disease

Key Drugs and Agents for Sarcoma

1. Doxorubicin (Adriamycin) : 56 outcomes 201 studies in 660 results : FDA 12 Generic
   
2. Ifosfamide : 42 outcomes 151 studies in 427 results : FDA 7 Generic
   
3. trabectedin (ecteinascidin 743) : 26 outcomes 53 studies in 170 results : IBA
   
4. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor) : 23 outcomes 18 studies in 196 results : IBA
   
5. Melphalan (Alkeran) : 22 outcomes 19 studies in 156 results : FDA 2 Generic
   
6. Cyclophosphamide (Cytoxan) : 16 outcomes 41 studies in 234 results : FDA 10 Generic
   
7. Cisplatin (Platino) : 14 outcomes 46 studies in 170 results : FDA 6 Generic
   
8. gemcitabine : 12 outcomes 28 studies in 79 results : FDA 7
   
9. pazopanib : 10 outcomes 22 studies in 67 results : IBA
   
10. Antigens : 8 outcomes 37 studies in 475 results : IBA
    

Diseases Related to Sarcoma

1. Neoplasms (Cancer)
2. Sarcoma (Soft Tissue Sarcoma)
3. Melanoma (Melanoma, Malignant)
4. Neoplasm Metastasis (Metastasis)
5. Carcinoma (Carcinomatosis)

Key Therapies for Sarcoma

1. Drug Therapy (Chemotherapy) : 160 outcomes 263 studies in 1630 results
   
2. Radiotherapy : 56 outcomes 105 studies in 1005 results
   
3. Adjuvant Chemotherapy : 20 outcomes 57 studies in 224 results
   
4. Brachytherapy : 17 outcomes 30 studies in 138 results
   
5. Combination Drug Therapy (Combination Chemotherapy) : 13 outcomes 21 studies in 121 results